Inflammation · Immunotherapy · Chronic Lyme
If you have been living with chronic Lyme disease for any length of time, you have probably encountered a frustrating pattern: treatment reduces symptoms for a while, then they return. Something triggers a flare. A good week is followed by several bad ones. The illness seems to have a life of its own — independent of whatever you try.
This is not coincidence, and it is not in your head. It reflects a specific biological reality: chronic Lyme disease establishes a self-sustaining inflammatory cycle that does not depend on continued active infection to perpetuate itself. Once this cycle is running, it continues on its own momentum — fed by dysfunctional immune cells, accumulated inflammatory molecules, and an internal environment so hostile that recovery becomes progressively harder to initiate.
Breaking this cycle is the central challenge of treating chronic Lyme. And it requires understanding exactly where and how the cycle sustains itself.
The cycle begins with Borrelia infection triggering an appropriate immune response — inflammation to fight the pathogen. In acute Lyme that resolves with treatment, this response eventually subsides. In chronic Lyme, it doesn't. The reasons are multiple and converging.
First, Borrelia's ability to persist in tissue — through biofilm formation, intracellular hiding, and antigen variation — means the immune system receives continued activation signals even when bacterial load is low. Second, the prolonged immune response depletes and destabilizes T-Regulatory cells, removing the mechanism that would normally bring the response to an end. Third, the accumulated products of sustained inflammation — pro-inflammatory cytokines, immune complexes, autoantibodies — themselves drive continued immune activation, independent of what the bacteria are doing.
By the time a patient has been ill for a year or more, the cycle has often become largely self-referential. The inflammation continues because the regulatory mechanism is broken. The regulatory mechanism stays broken because the inflammation perpetuates conditions that prevent it from recovering. The bacteria may be largely controlled — or even effectively absent — while the patient remains profoundly ill.
Why this matters for treatment: If chronic Lyme inflammation is self-sustaining, then treating only the bacteria cannot resolve it. An approach that addresses only pathogen burden leaves the dysfunctional immune architecture and toxic inflammatory environment fully intact — and the cycle continues.
The specific symptoms of chronic Lyme map almost precisely onto what sustained, unregulated inflammation does to the body's major systems.
The combined approach at the Lyme Immunotherapy Center does not target symptoms. It targets the specific points in the inflammatory cycle where intervention can interrupt the self-sustaining momentum — addressing the pathogen, the accumulated inflammatory burden, and the broken regulatory mechanism simultaneously.
Hyperthermia without apheresis mobilizes inflammatory debris without removing it — temporarily increasing the circulating burden before the immune system can clear it. Apheresis without Treg therapy removes the fuel but leaves the broken engine running — the cycle rebuilds the inflammatory burden it removes. Treg therapy without apheresis introduces regulatory cells into an environment saturated with the exact cytokines designed to destabilize them.
Each intervention creates a gap in the cycle. But the cycle has multiple self-reinforcing loops, and closing one gap is insufficient when the others remain open. The combined protocol is designed to close multiple gaps simultaneously — leaving the cycle without the inputs it needs to sustain itself.
The goal of treatment is not simply symptom relief — though that is what patients experience and measure. The deeper goal is restoration of the biological conditions that allow the body to heal itself: a regulated immune system, a cleared inflammatory environment, and a reduced pathogen burden.
When these conditions are restored, healing is not forced — it emerges. Sleep improves because the cytokines disrupting it have been reduced. Energy returns because the mitochondrial sabotage of IL-6 has been lifted. Cognitive function improves because neuroinflammation subsides. Joint pain decreases because immune complexes are cleared and the inflammatory signals driving local joint inflammation are reduced.
None of these changes are instantaneous — they follow the biological timeline of immune rebalancing, which unfolds over weeks and months. But they are genuine changes, rooted in the restoration of normal physiology rather than the management of abnormal symptoms. That is the difference between breaking the cycle and living within it.
Our team evaluates each patient to determine which combination of interventions best matches their inflammatory profile, disease history, and treatment goals.
Check My Eligibility